Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events

Abstract

Long QT syndrome (LQTS) is a disorder of the heart’s electrical activity that infrequently causes severe ventricular arrhythmias such as a type of ventricular tachycardia called torsade de pointes (TdP) and ventricular fibrillation, which can be fatal. There have been no previous reports on the time-to-onset for LQTS based on data from spontaneous reporting systems. The aim of this study was to assess the time-to-onset of LQTS according to drug treatment. We analyzed the association between 113 drugs in 37 therapeutic categories and LQTS including TdP using data obtained from the Japanese Adverse Drug Event Report database. For signal detection, we used the reporting odds ratio (ROR). Furthermore, we analyzed the time-to-onset data and assessed the hazard type using the Weibull shape parameter. The RORs (95% confidence interval) for bepridil, amiodarone, pilsicainide, nilotinib, disopyramide, arsenic trioxide, clarithromycin, cibenzoline, donepezil, famotidine, sulpiride, and nifekalant were 174.4 (148.6–204.6), 17.3 (14.7–20.4), 52.0 (43.4–62.4), 13.9 (11.5–16.7), 69.3 (55.3–86.8), 54.2 (43.2–68.0), 4.7 (3.8–5.8), 19.9 (15.9–25.0), 8.1 (6.5–10.1), 3.2 (2.5–4.1), 7.1 (5.5–9.2), and 254.8 (168.5–385.4), respectively. The medians and quartiles of time-to-onset for aprindine (oral) and bepridil were 20.0 (11.0–35.8) and 18.0 (6.0–43.0) days, respectively. The lower 95% confidence interval of the shape parameter β of bepridil was over 1 and the hazard was considered to increase over time.Our study indicated that the pattern of LQTS onset might differ among drugs. Based on these results, careful long-term observation is recommended, especially for specific drugs such as bepridil and aprindine. This information may be useful for the prevention of sudden death following LQTS and for efficient therapeutic planning.

Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015

“…SRS is one of the primary tools used in pharmacovigilance because they reflect the realities of clinical practice (Poluzzi et al., ). With larger numbers of faithful reports, the FAERS database should help for optimizing pharmacotherapy (Sasaoka et al., ). Furthermore, Concato et al.…”

“…SRS is one of the primary tools used in pharmacovigilance because they reflect the realities of clinical practice (Poluzzi et al, 2012). With larger numbers of faithful reports, the FAERS database should help for optimizing pharmacotherapy (Sasaoka et al, 2016). Furthermore, Concato et al reported that the results of well-designed observational studies do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic (Concato, Shah, & Horwitz, 2000).…”

Navigating the Minefield of QTc Interval‐Prolonging Therapy in Nursing Facility Residents

“…For our resident's medications, the peak occurrence is expected to be about 2 weeks following drug initiation; however, time to onset ranges widely from 2 to 30 days. Thus if ECG monitoring is implemented, it should extend for 2 to 4 weeks …”

“…Thus if ECG monitoring is implemented, it should extend for 2 to 4 weeks. 53 Table 3 outlines recommendations for issues unresolved in this population. In the absence of evidence in older adults, healthcare professionals remain accountable for optimizing drug therapy outcomes and minimizing the risk of adverse drug events.…”

Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database

“…If β is greater than 1 and the 95% CI of β excludes the value of 1, the hazard is considered to increase over time. [17][18][19][20]24,25) We investigated the relation between the number of reports and seasonality of DIP. We analyzed the onset day of AEs and then obtained the number of AE reports per month between April 2004 and November 2016 from REAC table of JADER.…”